TCTMD’s Top 10 Most Popular Stories for January 2017
Physician picks for the biggest news of 2016 and an in-depth look at rapid response teams to treat pulmonary embolism took top spots this month.
Embarking on 2017, the biggest news of January in fact came from 2016: TCTMD’s roundup of physician picks for the biggest news of last year. Other hits this month were a feature article on rapid-response teams for acute pulmonary embolism and, as part of a series we did on New Year’s resolutions, a detailed look at how alcohol affects the heart. We also saw interest in a slew of familiar topics: US Food and Drug Administration news, complete revascularization, radiation safety, acute kidney injury, and stroke in TAVR patients, among others.
TCTMD journalists asked a range of experts about what developments moved the needle this past year—either forwards or back.
The concept of a rapid response team for acute PE has spread quickly across the United States, although the impact remains unclear.
A Canadian data set sheds light on potential differences in treatment considerations for certain patient subgroups.
Califf left on January 20, the day of incoming President Donald Trump’s inauguration.
A pelvic drape, whether alone or combined with an arm drape, is most effective. But meaningful drops in radiation require a “culture” shift.
Want a pretty picture on your aspirin product packaging? You’ll also need a bold written reminder telling buyers to consult their doctors.
Small, nonrandomized study of coronary sinus aspiration shows feasibility, but some question if this invasive approach is the best option.
This was the first in a 4-part series of January 2017 stories looking at common New Year’s resolutions and their cardiac implications.
The in-hospital stroke rate was higher in patients with LAA thrombus, but a low number of events precludes definitive conclusions.
Stop, pause, or bridge: there is a lot of variability in how drug therapy for nonvalvular A-fib is managed during elective or urgent procedures.
Two other widely read stories this month were actually posted back in October during TCT 2016: late-breaking results from the EXCEL and NOBLE trials as well as from ABSORB II. To stay up to date with all our news stories and in-depth features as they go online, visit TCTMD’s News page.